决定异体 CAR T 细胞排斥与扩增的细胞和分子机制
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.
我们评估了11例接受单一批次cemacabtagene ansegedleucel(cema-cel)治疗的大B细胞淋巴瘤患者,cemacabtagene ansegedleucel是一种异体抗CD19 CAR T产品。
英文原题:Immunodeficiency with susceptibility to lymphoma with complex genotype affecting energy metabolism (FBP1, ACAD9) and vesicle trafficking (RAB27A).
淋巴瘤常见于HLH易感基因低效突变患者。我们假设FBP1和ACAD9的变异可能加重临床和免疫表型,影响CD8 T细胞的连续杀伤和裂解颗粒极化。理解全外显子测序(WES)所识别的多个变异之间的相互作用,对于正确解读免疫表型至关重要,并且对关键治疗决策具有重要意义。
先天性免疫缺陷(IEI)的特征是免疫系统功能障碍,导致对感染的易感性增加、免疫调节受损和癌症。我们报告了一个独特的近亲婚配家系,该家系有霍奇金淋巴瘤病史、EBV控制受损和迟发性噬血细胞性淋巴组织细胞增生症(HLH)。
总体而言,家庭成员表现为不同程度的NK细胞和细胞毒性T细胞脱颗粒及细胞毒性受损。外显子组测序鉴定出RAB27A、FBP1(果糖-1,6-二磷酸酶1)和ACAD9(酰基辅酶A脱氢酶家族成员9)的纯合变异。RAB27A变异可导致Griscelli综合征2型、色素减退及HLH易感性。
INTRODUCTION: Inborn errors of immunity (IEI) are characterized by a dysfunction of the immune system leading to increased susceptibility to infections, impaired immune regulation and cancer. We present a unique consanguineous family with a history of Hodgkin lymphoma, impaired EBV control and a late onset hemophagocytic lymphohistiocytosis (HLH). METHODS AND RESULTS: Overall, family members presented with variable impairment of NK cell and cytotoxic T cell degranulation and cytotoxicity. Exome sequencing identified homozygous variants in RAB27A , FBP1 ( Fructose-1,6-bisphosphatase 1 ) and ACAD9 ( Acyl-CoA dehydrogenase family member 9 ). Variants in RAB27A lead to Griscelli syndrome type 2, hypopigmentation and HLH predisposition. DISCUSSION: Lymphoma is frequently seen in patients with hypomorphic mutations of genes predisposing to HLH. We hypothesize that the variants in FBP1 and ACAD9 might aggravate the clinical and immune phenotype, influence serial killing and lytic granule polarization by CD8 T cells. Understanding of the interplay between the multiple variants identified by whole exome sequencing (WES) is essential for correct interpretation of the immune phenotype and important for critical treatment decisions.
MEMBER ACCOUNT
登录成功会直接打开下一页。